BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 11703090)

  • 21. Transforming growth factor-beta signaling in cancer.
    Rich J; Borton A; Wang X
    Microsc Res Tech; 2001 Feb; 52(4):363-73. PubMed ID: 11170295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical expression of Smads 1-6 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-betas.
    Flanders KC; Kim ES; Roberts AB
    Dev Dyn; 2001 Feb; 220(2):141-54. PubMed ID: 11169847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-beta signalling from cell membrane to nucleus through SMAD proteins.
    Heldin CH; Miyazono K; ten Dijke P
    Nature; 1997 Dec; 390(6659):465-71. PubMed ID: 9393997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of transcription factors involved in TGFbeta superfamily signaling during development.
    Watanabe M; Whitman M
    Cell Mol Biol (Noisy-le-grand); 1999 Jul; 45(5):537-43. PubMed ID: 10512186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
    Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
    Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
    J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling.
    Watanabe Y; Itoh S; Goto T; Ohnishi E; Inamitsu M; Itoh F; Satoh K; Wiercinska E; Yang W; Shi L; Tanaka A; Nakano N; Mommaas AM; Shibuya H; Ten Dijke P; Kato M
    Mol Cell; 2010 Jan; 37(1):123-34. PubMed ID: 20129061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer.
    Kleeff J; Maruyama H; Friess H; Büchler MW; Falb D; Korc M
    Biochem Biophys Res Commun; 1999 Feb; 255(2):268-73. PubMed ID: 10049697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
    Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
    Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation and regulatory activities of transforming growth factor beta.
    Bonewald LF
    Crit Rev Eukaryot Gene Expr; 1999; 9(1):33-44. PubMed ID: 10200910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of TGFbeta in human cancers.
    Wong SF; Lai LC
    Pathology; 2001 Feb; 33(1):85-92. PubMed ID: 11280615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of type III TGF-β receptor aggravates lung fibrotic process.
    Ahn JY; Park S; Yun YS; Song JY
    Biomed Pharmacother; 2010 Sep; 64(7):472-6. PubMed ID: 20359848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interaction between two TGF-beta type I receptors plays important roles in ligand binding, SMAD activation, and gradient formation.
    Haerry TE
    Mech Dev; 2010; 127(7-8):358-70. PubMed ID: 20381612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cellular signaling in response to TGFbeta: the paradox of a factor that blocks cell proliferation and enhances metastasis].
    Vignais ML
    Bull Cancer; 1999 Nov; 86(11):903-10. PubMed ID: 10586106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transforming growth factor-beta signaling and cancer].
    Miyazono K
    Hum Cell; 2000 Sep; 13(3):97-101. PubMed ID: 11197777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
    Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
    Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis.
    Zwijsen A; van Rooijen MA; Goumans MJ; Dewulf N; Bosman EA; ten Dijke P; Mummery CL; Huylebroeck D
    Dev Dyn; 2000 Aug; 218(4):663-70. PubMed ID: 10906784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of Smad6 and Smad7 in the rat kidney and their regulated expression in the anti-Thy-1 nephritis.
    Uchida K; Nitta K; Kobayashi H; Kawachi H; Shimizu F; Yumura W; Nihei H
    Mol Cell Biol Res Commun; 2000 Aug; 4(2):98-105. PubMed ID: 11170839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-beta signaling by Smad proteins.
    Miyazono K; ten Dijke P; Heldin CH
    Adv Immunol; 2000; 75():115-57. PubMed ID: 10879283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Smad family and its role in pancreatic cancer.
    Singh P; Wig JD; Srinivasan R
    Indian J Cancer; 2011; 48(3):351-60. PubMed ID: 21921337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.